Predicting pancreatic cancer risk using diverse health data

Integrating epidemiologic, clinical, genomic and metabolomic profiles to predict pancreatic cancer risk in a multiethnic population

NIH-funded research University of Southern California · NIH-11005721

This study is looking to better predict who might be at risk for pancreatic cancer by combining different health information from a large and diverse group of people, so we can help identify those who need closer monitoring and early detection.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Southern California NIH-funded
Lab location1 site (Los Angeles, UNITED STATES)
Project IDNIH-11005721 on NIH RePORTER

What this research studies

This research aims to improve the prediction of pancreatic cancer risk by integrating various health data, including epidemiologic, clinical, genomic, and metabolomic profiles from a diverse population. By utilizing the Multiethnic Cohort Study, which includes over 215,000 individuals from different racial and ethnic backgrounds, the study seeks to develop a more accurate model for identifying high-risk individuals. This approach considers a wide range of factors, including lifestyle, environmental influences, and genetic information, to enhance early detection of pancreatic cancer.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals from diverse racial and ethnic backgrounds, particularly those with a family history of pancreatic cancer or other risk factors.

Not a fit: Patients who do not belong to the targeted multiethnic populations or those without any known risk factors for pancreatic cancer may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to better screening and early detection strategies for pancreatic cancer, particularly in high-risk populations.

How similar studies have performed: Previous research has shown promise in using integrated health data for cancer risk prediction, but this specific approach focusing on a multiethnic population is novel.

Where this research is happening

Los Angeles, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.